Search Ontology:
ChEBI
ritanserin
- Term ID
- CHEBI:64195
- Synonyms
-
- 6-(2-(4-(bis(p-fluorophenyl)methylene)-piperidino)ethyl)-7-methyl-5H-thiazolo-(3,2-a)pyrimidin-5-one
- 6-(2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl)-7-methyl-5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one
- R 55,667
- R-55667
- ritanserin
- ritanserina
- ritanserine
- ritanserinum
- Definition
- A thiazolopyrimidine that is 5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one which is substituted at position 7 by a methyl group and at position 6 by a 2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl group. A potent and long-acting seratonin (5-hydroxytryptamine, 5-HT) antagonist of the subtype 5-HT2 (Ki = 0.39 nM), it is used in the treatment of a variety of disorders including anxiety, depression and schizophrenia. It has little sedative action.
- References
-
- CAS:87051-43-2
- KEGG:D05738
- LINCS:LSM-2906
- PMID:11897543
- PMID:12905101
- PMID:18801405
- PMID:20825390
- PMID:8974378
- Patent:US4533665
- Reaxys:4913835
- Wikipedia:Ritanserin
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
- is a type of
-
- has_role
Phenotype
Phenotype resulting from ritanserin
Phenotype where environments contain ritanserin
Phenotype modified by environments containing ritanserin
Human Disease Model